LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE |
202171 |
001 |
NDA |
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE |
TABLET; ORAL |
300MG; 300MG; 200MG |
No
|
No
|
2011/09/08
(TA)
|
--
|
MATRIX LABS LTD |
None (Tentative Approval) |
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE |
204505 |
001 |
NDA |
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE |
TABLET; ORAL |
300MG; 300MG; 200MG |
No
|
No
|
2013/10/18
(TA)
|
--
|
AUROBINDO PHARMA LTD |
None (Tentative Approval) |
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE |
205355 |
001 |
NDA |
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE |
TABLET; ORAL |
300MG; 300MG; 200MG |
No
|
No
|
2014/03/14
(TA)
|
--
|
HETERO LABS LTD III |
None (Tentative Approval) |